Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Continuous in-home PM2.5 concentrations of smokers with and without a history of respiratory exacerbations in Iowa, during and after an air purifier intervention



Americans spend most of their time indoors. Indoor particulate matter (PM) 2.5 µm and smaller (PM2.5) concentrations often exceed ambient concentrations. Therefore, we tested whether the use of an air purifying device (electrostatic precipitator, ESP) could reduce PM2.5 in homes of smokers with and without respiratory exacerbations, compared with baseline.


We assessed PM2.5 concentrations in homes of subjects with and without a recent (≤3 years) history of respiratory exacerbation. We compared PM2.5 concentrations during 1 month of ESP use with those during 1 month without ESP use.


Our study included 19 subjects (53–80 years old), nine with a history of respiratory exacerbation. Geometric mean (GM) PM2.5 and median GM daily peak PM2.5 were significantly lower during ESP deployment compared with the equivalent time-period without the ESP (GSD = 0.50 and 0.37 µg/m3, respectively, p < 0.001). PM2.5 in homes of respiratory exacerbators tended (p < 0.14) to be higher than PM2.5 in homes of those without a history of respiratory exacerbation.


Subjects with a history of respiratory exacerbation tended to have higher mean, median, and mean peak PM2.5 concentrations compared with homes of subjects without a history of exacerbations. The ESP intervention reduced in-home PM2.5 concentrations, demonstrating its utility in reducing indoor exposures.

Novelty of study

Our work characterizes PM air pollution concentrations in homes of study subjects with and without respiratory exacerbations. We demonstrate that PM concentrations tend to be higher in homes of participants with respiratory exacerbations, and that the use of an inexpensive air purifier resulted in significantly lower daily average PM concentrations than when the purifier was not present. Our results provide a helpful intervention strategy for purifying indoor air and may be useful for susceptible populations.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Log-transformed PM2.5 concentrations during and after ESP deployment.
Fig. 2: Average daily, average peak daily, and median peak daily PM2.5 concentrations, grouped by respiratory exacerbation status; to be considered within the exacerbator group, subjects had experienced ≥ 1 exacerbation per year within the previous three years (2015–2017), while non-exacerbators had not experienced any exacerbations within the prior three years.

Code availability

To access the available code used in our analysis, please contact the corresponding author.


  1. Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, et al. Short-term elevation of fine particulate matter air pollution and acute lower respiratory infection. Am J Respir Crit Care Med. 2018;198:759–66.

    Article  Google Scholar 

  2. Dockery DW, Pope CA. Acute respiratory effects of particulate air pollution. Annu Rev Public Health. 1994;15:107–32.

    Article  CAS  Google Scholar 

  3. Peel JL, Tolbert PE, Klein M, Metzger KB, Flanders WD, Todd K, et al. Ambient air pollution and respiratory emergency department visits. Epidemiology. 2005;16:164–74.

    Article  Google Scholar 

  4. Kim JJ, Smorodinsky S, Lipsett M, Singer BC, Hodgson AT, Ostro B. Traffic-related air pollution near busy roads: the East Bay Children’s Respiratory Health Study. Am J Respir Crit Care Med. 2004;170:520–6.

    Article  Google Scholar 

  5. Clark NA, Demers PA, Karr CJ, Koehoorn M, Lencar C, Tamburic L, et al. Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect. 2010;118:284–90.

    Article  CAS  Google Scholar 

  6. Ni L, Chuang C-C, Zuo L. Fine particulate matter in acute exacerbation of COPD. Front Physiol. 2015;6:294.

    Article  Google Scholar 

  7. Kumar N, Liang D, Comellas A, Chu AD, Abrams T. Satellite-based PM concentrations and their application to COPD in Cleveland, OH. J Expo Sci Environ Epidemiol. 2013;23:637–46.

    Article  CAS  Google Scholar 

  8. Sint T, Donohue JF, Ghio AJ. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhal Toxicol 2008;20:25–9.

    Article  CAS  Google Scholar 

  9. Hansel NN, McCormack MC, Belli AJ, Matsui EC, Peng RD, Aloe C, et al. In-home air pollution is linked to respiratory morbidity in former smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:1085–90.

    Article  Google Scholar 

  10. Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, et al. The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Sci Environ Epidemiol. 2001;11:231–52.

    Article  CAS  Google Scholar 

  11. Wheeler AJ, Wallace LA, Kearney J, Van Ryswyk K, You H, Kulka R, et al. Personal, indoor, and outdoor concentrations of fine and ultrafine particles using continuous monitors in multiple residences. Aerosol Sci Technol. 2011;45:1078–89.

    Article  CAS  Google Scholar 

  12. Gao M, Cao J, Seto E. A distributed network of low-cost continuous reading sensors to measure spatiotemporal variations of PM2. 5 in Xi’an, China. Environ Pollut 2015;199:56–65.

    Article  CAS  Google Scholar 

  13. Jiao W, Hagler G, Williams R, Sharpe R, Brown R, Garver D, et al. Community Air Sensor Network (CAIRSENSE) project: evaluation of low-cost sensor performance in a suburban environment in the southeastern United States. Atmos Meas Tech. 2016;9:5281–92.

    Article  CAS  Google Scholar 

  14. Ramachandran G, Adgate JL, Hill N, Sexton K, Pratt GC, Bock D. Comparison of short-term variations (15-minute averages) in outdoor and indoor PM2. 5 concentrations. J Air Waste Manag Assoc. 2000;50:1157–66.

    Article  CAS  Google Scholar 

  15. Fromme H, Diemer J, Dietrich S, Cyrys J, Heinrich J, Lang W, et al. Chemical and morphological properties of particulate matter (PM10, PM2. 5) in school classrooms and outdoor air. Atmos Environ. 2008;42:6597–605.

    Article  CAS  Google Scholar 

  16. Michaels RA, Kleinman MT. Incidence and apparent health significance of brief airborne particle excursions. Aerosol Sci Technol. 2000;32:93–105.

    Article  CAS  Google Scholar 

  17. Adams H, Nieuwenhuijsen M, Colvile R, McMullen M, Khandelwal P. Fine particle (PM2.5) personal exposure levels in transport microenvironments, London, UK. Sci Total Environ. 2001;279:29–44.

    Article  CAS  Google Scholar 

  18. Kingham S, Meaton J, Sheard A, Lawrenson O. Assessment of exposure to traffic-related fumes during the journey to work. Transp Res Part D. 1998;3:271–4.

    Article  Google Scholar 

  19. Ruuskanen J, Tuch T, Ten Brink H, Peters A, Khlystov A, Mirme A, et al. Concentrations of ultrafine, fine and PM2.5 particles in three European cities. Atmos Environ. 2001;35:3729–38.

    Article  CAS  Google Scholar 

  20. He K, Yang F, Ma Y, Zhang Q, Yao X, Chan CK, et al. The characteristics of PM2.5 in Beijing, China. Atmos Environ 2001;35:4959–70.

    Article  CAS  Google Scholar 

  21. Onat B, Stakeeva B. Personal exposure of commuters in public transport to PM2.5 and fine particle counts. Atmos Pollut Res. 2013;4:329–35.

    Article  CAS  Google Scholar 

  22. Karottki DG, Spilak M, Frederiksen M, Gunnarsen L, Brauner EV, Kolarik B, et al. An indoor air filtration study in homes of elderly: cardiovascular and respiratory effects of exposure to particulate matter. Environ Health 2013;12:116.

    Article  Google Scholar 

  23. National Academies of Sciences, Engineering, Medicine. Sources of indoor particulate matter. Health risks of indoor exposure to particulate matter: workshop summary. National Academies Press (US), Washington (DC); 2016.

  24. Parker GJ, Ong CH, Manges RB, Stapleton EM, Comellas AP, Peters TM, et al. A novel method to collect and chemically characterize milligram quantities of airborne indoor particulate matter. Aerosol Air Qual Res. 2019;19:2387–95.

  25. Ong CH. Electrostatic precipitator to collect large quantities of particulate matter [MS]. Iowa City, IA: University of Iowa; 2017.

    Google Scholar 

  26. Parker KR. Why an electrostatic precipitator? In: Applied electrostatic precipitation. Springer, Dordrecht; 1997. p. 1–10.

  27. McCain JD, Gooch JP, Smith WB. Results of field measurements of industrial particulate sources and electrostatic precipitator performance. J Air Pollut Control Assoc. 1975;25:117–21.

    Article  CAS  Google Scholar 

  28. Sousan S, Koehler K, Hallett L, Peters TM. Evaluation of consumer monitors to measure particulate matter. J aerosol Sci. 2017;107:123–33.

    Article  CAS  Google Scholar 

  29. Gordon T, Nadziejko C, Schlesinger R, Chen LC. Pulmonary and cardiovascular effects of acute exposure to concentrated ambient particulate matter in rats. Toxicol Lett. 1998;96:285–8.

    Article  Google Scholar 

  30. Miyata R, van Eeden SF. The innate and adaptive immune response induced by alveolar macrophages exposed to ambient particulate matter. Toxicol Appl Pharmacol. 2011;257:209–26.

    Article  CAS  Google Scholar 

  31. Xing Y-F, Xu Y-H, Shi M-H, Lian Y-X. The impact of PM2.5 on the human respiratory system. J Thorac Dis. 2016;8:E69.

    Article  Google Scholar 

  32. McCain RW, Holden EP, Blackwell TR, Christman JW. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro. Am J Respir Cell Mol Biol. 1994;10:651–7.

    Article  CAS  Google Scholar 

  33. Marchini T, Magnani ND, Paz ML, Vanasco V, Tasat D, Maglio DG, et al. Time course of systemic oxidative stress and inflammatory response induced by an acute exposure to residual oil fly ash. Toxicol Appl Pharmacol. 2014;274:274–82.

    Article  CAS  Google Scholar 

  34. Aarnio P, Yli-Tuomi T, Kousa A, Mäkelä T, Hirsikko A, Hämeri K, et al. The concentrations and composition of and exposure to fine particles (PM2. 5) in the Helsinki subway system. Atmos Environ. 2005;39:5059–66.

    Article  CAS  Google Scholar 

  35. Pillarisetti A, Carter E, Rajkumar S, Young BN, Benka-Coker ML, Peel JL, et al. Measuring personal exposure to fine particulate matter (PM2. 5) among rural Honduran women: a field evaluation of the Ultrasonic Personal Aerosol Sampler (UPAS). Environ Int. 2019;123:50–3.

    Article  CAS  Google Scholar 

  36. Mizuno A. Electrostatic precipitation. IEEE Trans Dielectr Electr Insul. 2000;7:615–24.

    Article  CAS  Google Scholar 

  37. Lehtimäki M, Heinonen K. Reliability of electret filters. Build Environ. 1994;29:353–5.

    Article  Google Scholar 

  38. Jaworek A, Krupa A, Sobczyk AT, Marchewicz A, Szudyga M, Antes T, et al. Submicron particles removal by charged sprays. Fundamentals. J Electrost. 2013;71:345–50.

    Article  CAS  Google Scholar 

  39. Saiyasitpanich P, Keener TC, Khang S-J, Lu M. Removal of diesel particulate matter (DPM) in a tubular wet electrostatic precipitator. J Electrost. 2007;65:618–24.

    Article  CAS  Google Scholar 

  40. Knol AB, de Hartog JJ, Boogaard H, Slottje P, van der Sluijs JP, Lebret E, et al. Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol. 2009;6:19.

    Article  Google Scholar 

  41. Kumar P, Morawska L, Birmili W, Paasonen P, Hu M, Kulmala M, et al. Ultrafine particles in cities. Environ Int. 2014;66:1–10.

    Article  CAS  Google Scholar 

  42. McCormack MC, Belli AJ, Kaji DA, Matsui EC, Brigham EP, Peng RD, et al. Obesity as a susceptibility factor to indoor particulate matter health effects in COPD. Eur Respir J. 2015;45:1248–57.

    Article  Google Scholar 

Download references


We would like to thank all study participants for their willingness to maintain both the Foobot and ESP device throughout the study period.


This work was partly supported by the Origins of Cystic Fibrosis Airway Disease PPG grant (HL091842-11) funded by the National Institutes of Health. Additional funding for this study was provided by The University of Iowa Institute for Clinical and Translational Science, NIH U54 TR001356, and the Environmental Health Sciences Research Center, NIH P30 ES005605.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Emma M. Stapleton.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stapleton, E.M., Simmering, J.E., Manges, R.B. et al. Continuous in-home PM2.5 concentrations of smokers with and without a history of respiratory exacerbations in Iowa, during and after an air purifier intervention. J Expo Sci Environ Epidemiol 30, 778–784 (2020).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Particulate matter
  • Pulmonary disease
  • Environmental monitoring
  • Air pollution (or Air quality)
  • Exposure assessment


Quick links